New medical oncologist joins CMH
Contact: Sarah Bello
Sliesoraitis is third medical oncology provider at CMH-OHSU Knight Cancer Collaborative
CMH is pleased to welcome Sarunas Sliesoraitis, DO, PharmD, to the CMH-OHSU Knight Cancer Collaborative, where he is a new medical oncologist.
Dr. Sliesoraitis most recently worked for Intermountain Medical Group at Logan Regional Hospital in Logan, Utah. During his career, he has also worked as an assistant professor in pharmacy practice and as a staff pharmacist. Early in his career, he worked as a medic and nursing assistant for the U.S. Army National Guard.
Dr. Sliesoraitis earned his medical degree from Lake Erie College of Osteopathic Medicine in Erie, Pennsylvania, and his doctorate of pharmacy degree from the University of Connecticut in Mansfield, Connecticut. He also holds a graduate certificate in translational health science from the University of Florida in Gainesville, Florida.
During his studies, Dr. Sliesoraitis completed a fellowship in advanced oncology-hematology drug development through the University of Texas Health Science Center in San Antonio, Texas. He also completed a fellowship in hematology/oncology at the University of Florida.
His internal medicine residency was completed at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina; an oncology pharmacy practice residency at H. Lee Moffitt Cancer & Research Center in Tampa, Florida; and a pharmacy practice residency at Froedtert Memorial Lutheran Hospital in Milwaukee, Wisconsin.
During his career, Dr. Sliesoraitis has received several awards. His work has been published in several publications, highlighting research on both oncology and pharmacology.
Dr. Sliesoraitis is a member of the American Society of Clinical Oncology, American Society of Hematology and many honors societies. He is fluent in Lithuanian.